▲ 0.35%
prev close
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Congressional Trades
5
All tracked trades
Members Trading
4
Unique members
Net Activity
+3
4 buys · 1 sells
Members Who Traded This Stock
5 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-07-23 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 231d ago | — | |
| 2025-06-17 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 232d ago | — | |
| 2025-06-11 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 266d ago | — | |
| 2025-02-28 | RVTYRevvity, Inc. Common Stock | Sell | $15,001 - $50,000 | 378d ago | — | |
| 2025-02-25 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 371d ago | — |
2025-07-23
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
231d ago
2025-06-17
Lisa McClain
RVTY
Amount
$1,001 - $15,000
Filed
232d ago
2025-06-11
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
266d ago
2025-02-28
April McClain Delaney
RVTY
Amount
$15,001 - $50,000
Filed
378d ago
2025-02-25
Rob Bresnahan
RVTY
Amount
$1,001 - $15,000
Filed
371d ago
Recent News
Powered by Polygon.io
Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor Intelligence
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization
Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED)
Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday?
Revvity Slashes Outlook As China Policy Deals Diagnostics Blow
Trade Timeline
Congressional activity, newest first
Gilbert Cisneros
2025-07-23 · Purchase
$1,001 - $15,000
Lisa McClain
2025-06-17 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-06-11 · Purchase
$1,001 - $15,000
April McClain Delaney
2025-02-28 · Sale
$15,001 - $50,000
Rob Bresnahan
2025-02-25 · Purchase
$1,001 - $15,000